COMPANY OVERVIEW
MeSCue-Janusys Inc. is a Biotech venture company addressing high unmet medical needs particularly in the field of periodontal and neurodegenerative diseases.
Our company aspires to improve the health of patients by commercially exploiting the therapeutic potential of our novel peptides.
We aim to fundamentally improve the quality of life for patients and helping to reduce overall healthcare costs by providing innovative therapies with our proprietary technologies.
Vision
to meet the unmet medical needs by using innovative therapies and diagnostic tools.
Mission
to bring innovative science and technology together for the development of effective and tolerable therapy
COMPANY STORY
2003
Janusys incorporated as independent spinoff of AIST*
2015
MeSCue incorporated as independent spinoff of AIST
2016
Janusys selected as one of 100 most innovative Japanese ventures
2017
MeSCue acquired Janusys and became MeSCue-Janusys
Board of Directors
Koichiro Kitamura Ph.D.
President & Chief Executive Officer (CEO)
Naoto Kagiyama Ph.D.
Executive Vice President & Founder
Yasushi Takagi
Director
Kazuo Hayakawa
Auditor
Advisors
Waleed Osman, VMD, Ph.D.
Senior Advisor
Michio Oishi, Ph.D.
Scientific Advisor, Chairman of “Kazusa DNA Research Institute”